A Platform Promoting Inter-Physician Interaction to Support the Management of Adverse Drug Reactions for CLL Patients

Area of Science:

• Oncology
• Pharmacology
• Health Informatics

Background:

• Adverse Drug Reactions (ADRs) negatively affect patient Quality of Life (QoL) and escalate healthcare expenditures, especially in managing chronic diseases.
• Chronic Lymphocytic Leukemia (CLL) management presents challenges due to potential ADRs and the need for specialized care.
• Effective communication and expert consultation are crucial for optimizing treatment strategies and mitigating ADRs in CLL patients.

Purpose of the Study:

• To propose an innovative eHealth platform designed to enhance the management of patients diagnosed with Chronic Lymphocytic Leukemia (CLL).
• To facilitate seamless inter-physician communication and collaboration in the context of CLL patient care.
• To provide specialized consultation services for Adverse Drug Reaction (ADR) management, leveraging a dedicated team of CLL experts.

Main Methods:

• Development and implementation of a secure eHealth platform.
• Integration of communication tools for inter-physician interaction.
• Establishment of a specialized ADR management team comprising CLL experts for consultation.

Main Results:

• The platform facilitates improved communication channels between healthcare providers involved in CLL care.
• Access to expert consultation for ADR management is enhanced, potentially leading to more informed treatment decisions.
• The proposed system aims to streamline the management process for CLL patients experiencing ADRs.

Conclusions:

• The eHealth platform offers a promising solution for improving the quality of care for CLL patients by addressing ADRs.
• Enhanced inter-physician collaboration and expert consultation are key components for effective management of chronic diseases like CLL.
• This initiative supports a patient-centered approach to managing complex conditions, focusing on both treatment efficacy and quality of life.